These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 19870353

  • 1. FURTHER STUDIES ON KALA-AZAR : LEISHMANIA IN NASAL AND ORAL SECRETIONS OF PATIENTS AND THE BEARING OF THIS FINDING ON THE TRANSMISSION OF THE DISEASE.
    Forkner CE, Zia LS.
    J Exp Med; 1935 Jan 31; 61(2):183-203. PubMed ID: 19870353
    [Abstract] [Full Text] [Related]

  • 2. VIABLE LEISHMANIA DONOVANI IN NASAL AND ORAL SECRETIONS OF PATIENTS WITH KALA-AZAR AND THE BEARING OF THIS FINDING ON THE TRANSMISSION OF THE DISEASE.
    Forkner CE, Zia LS.
    J Exp Med; 1934 Mar 31; 59(4):491-9. PubMed ID: 19870261
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P, Samantaray J, Chauhan NK.
    Indian J Med Res; 2005 Dec 31; 122(6):485-90. PubMed ID: 16517998
    [Abstract] [Full Text] [Related]

  • 4. Leishmania donovani parasites in the nasal secretions, tonsillopharyngeal mucosa, and urine centrifugates of visceral leishmaniasis patients in Kenya.
    Mebrahtu YB, Hendricks LD, Oster CN, Lawyer PG, Perkins PV, Pamba H, Koech D, Roberts CR.
    Am J Trop Med Hyg; 1993 Apr 31; 48(4):530-5. PubMed ID: 8480861
    [Abstract] [Full Text] [Related]

  • 5. A new strategy for elimination of kala-azar from rural Bihar.
    Thakur CP.
    Indian J Med Res; 2007 Nov 31; 126(5):447-51. PubMed ID: 18160749
    [Abstract] [Full Text] [Related]

  • 6. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S, Bajracharya BL, Baral MR.
    Kathmandu Univ Med J (KUMJ); 2006 Nov 31; 4(2):232-4. PubMed ID: 18603904
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis of symptomatic kala-azar by polymerase chain reaction using patient's blood.
    Pal S, Aggarwal G, Haldar A, Majumdar A, Majumdar HK, Duttagupta S.
    Med Sci Monit; 2004 Jan 31; 10(1):MT1-5. PubMed ID: 14704640
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients.
    Singh A, Ramesh V, Ramam M.
    Indian J Dermatol Venereol Leprol; 2015 Jan 31; 81(1):29-34. PubMed ID: 25566893
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quantitative grading of Leishmania donovani amastigotes related to age of kala-azar patients.
    Saran R, Sharma MC, Sen AB.
    J Commun Dis; 1989 Dec 31; 21(4):262-4. PubMed ID: 2638374
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis.
    Zijlstra EE, el-Hassan AM, Ismael A.
    Am J Trop Med Hyg; 1995 Apr 31; 52(4):299-305. PubMed ID: 7741164
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology of Post-Kala-azar Dermal Leishmaniasis.
    Ghosh P, Roy P, Chaudhuri SJ, Das NK.
    Indian J Dermatol; 2021 Apr 31; 66(1):12-23. PubMed ID: 33911289
    [Abstract] [Full Text] [Related]

  • 16. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
    Sarraf NR, Mukhopadhyay S, Banerjee A, Das AK, Roy S, Chakrabarti S, Manna M, Saha P.
    Acta Trop; 2021 Nov 31; 223():106086. PubMed ID: 34389331
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
    Singh S, Kumar J, Singh R, Dwivedi SN.
    Int J Infect Dis; 2000 Nov 31; 4(4):203-8. PubMed ID: 11231183
    [Abstract] [Full Text] [Related]

  • 18. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child.
    Meinecke CK, Schottelius J, Oskam L, Fleischer B.
    Pediatrics; 1999 Nov 31; 104(5):e65. PubMed ID: 10545591
    [Abstract] [Full Text] [Related]

  • 19. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment.
    el-Hassan AM, Meredith SE, Yagi HI, Khalil EA, Ghalib HW, Abbas K, Zijlstra EE, Kroon CC, Schoone GJ, Ismail A.
    Trans R Soc Trop Med Hyg; 1995 Nov 31; 89(6):647-52. PubMed ID: 8594683
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.